Cart
sales@molnova.com
Ekersenin
CAS No. 53091-74-0
Ekersenin( ——— )
Catalog No. M38511 CAS No. 53091-74-0
Ekersenin is a natural product that can be isolated from Ekererbegia senegalensis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEkersenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionEkersenin is a natural product that can be isolated from Ekererbegia senegalensis.
-
DescriptionEkersenin is a natural product that can be isolated from Ekererbegia senegalensis.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number53091-74-0
-
Formula Weight190.2
-
Molecular FormulaC11H10O3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Okogun J I, et al. Spectral studies on coumarins and the determination of the constitution of ekersenin by total synthesis. Tetrahedron, 1978, 34(8): 1221-1224.
molnova catalog
related products
-
δ-Valerolactone
δ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.
-
GSK2983559 free acid
GSK2983559 free acid is an effective and selective inhibitor of receptor-interacting protein 2 (RIP2).
-
Compound K
HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.
